Handel OPKO Health, Inc. - OPK CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Spænd | 0.0256 | ||||||||
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.030779% | ||||||||
Short position, gebyr natten over
Short position overnight fee
Gå til platform | -0.013666% | ||||||||
Gebyr natten over, tid | 22:00 (UTC) | ||||||||
Min. handlet mængde | 1 | ||||||||
Valuta | USD | ||||||||
Margen | 20% | ||||||||
Aktiebørs | United States of America | ||||||||
Kommission på handel | 0% |
*Information provided by Capital.com
Tidligere luk* | 1.3772 |
Åben* | 1.4272 |
1-Års Ændring* | -54.11% |
Dagens Spænd* | 1.3373 - 1.4272 |
52-Ugers Spænd | 1.03-3.78 |
Gennemsnitlig Volumen (10 dage) | 2.62M |
Gennemsnitlig Volumen (3 måneder) | 52.21M |
Market Cap | 996.77M |
P/E-forhold | -100.00K |
Udestående aktier | 772.69M |
Omsætning | 1.22B |
EPS | -0.45 |
Dividend (Udbytte %) | N/A |
Beta | 1.69 |
Næste indtjeningsopgørelse | Feb 22, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Luk | Change | Change (%) | Åben | High | Low |
---|---|---|---|---|---|---|
Feb 1, 2023 | 1.3772 | 0.1098 | 8.66% | 1.2674 | 1.4272 | 1.2575 |
Jan 31, 2023 | 1.2774 | 0.0399 | 3.22% | 1.2375 | 1.2874 | 1.2375 |
Jan 30, 2023 | 1.2275 | 0.0000 | 0.00% | 1.2275 | 1.2575 | 1.2175 |
Jan 27, 2023 | 1.2475 | 0.0300 | 2.46% | 1.2175 | 1.2774 | 1.2076 |
Jan 26, 2023 | 1.2475 | -0.0199 | -1.57% | 1.2674 | 1.2675 | 1.2175 |
Jan 25, 2023 | 1.2974 | 0.0100 | 0.78% | 1.2874 | 1.3174 | 1.2475 |
Jan 24, 2023 | 1.3174 | -0.0598 | -4.34% | 1.3772 | 1.3772 | 1.2774 |
Jan 23, 2023 | 1.3772 | -0.0599 | -4.17% | 1.4371 | 1.4471 | 1.3673 |
Jan 20, 2023 | 1.4870 | 0.0399 | 2.76% | 1.4471 | 1.5070 | 1.4371 |
Jan 19, 2023 | 1.4671 | -0.1197 | -7.54% | 1.5868 | 1.5869 | 1.4571 |
Jan 18, 2023 | 1.5968 | 0.0000 | 0.00% | 1.5968 | 1.6667 | 1.5769 |
Jan 17, 2023 | 1.5769 | 0.0200 | 1.28% | 1.5569 | 1.6567 | 1.5070 |
Jan 13, 2023 | 1.5669 | 0.2396 | 18.05% | 1.3273 | 1.5869 | 1.3174 |
Jan 12, 2023 | 1.3174 | 0.0300 | 2.33% | 1.2874 | 1.3174 | 1.2774 |
Jan 11, 2023 | 1.2974 | 0.0299 | 2.36% | 1.2675 | 1.3074 | 1.2575 |
Jan 10, 2023 | 1.2575 | 0.0300 | 2.44% | 1.2275 | 1.2575 | 1.2275 |
Jan 9, 2023 | 1.2275 | 0.0000 | 0.00% | 1.2275 | 1.2675 | 1.1976 |
Jan 6, 2023 | 1.2675 | 0.0400 | 3.26% | 1.2275 | 1.2675 | 1.1876 |
Jan 5, 2023 | 1.2275 | -0.0200 | -1.60% | 1.2475 | 1.2675 | 1.2076 |
Jan 4, 2023 | 1.2774 | 0.0798 | 6.66% | 1.1976 | 1.2774 | 1.1876 |
OPKO Health, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Årlig
- Pr kvartal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total omsætning | 1117.49 | 966.006 | 990.266 | 901.935 | 1435.41 | 1774.72 |
Omsætning | 1117.49 | 966.006 | 990.266 | 901.935 | 1435.41 | 1774.72 |
Kost af omsætning, Total | 611.482 | 620.13 | 604.636 | 572.484 | 894.408 | 1193.19 |
Bruttofortjeneste | 506.012 | 345.876 | 385.63 | 329.451 | 541.005 | 581.524 |
Totale Driftsudgifter | 1214.05 | 1242.45 | 1161.46 | 1175.99 | 1377.7 | 1755.97 |
Salgs/Generelle/Admin. Udgifter, Total | 398.431 | 408.828 | 353.446 | 340.305 | 354.573 | 468.857 |
Forskning & Udvikling | 113.871 | 126.435 | 125.586 | 117.87 | 75.316 | 76.85 |
Depreciation / Amortization | 64.407 | 71.484 | 67.933 | 64.783 | 56.391 | 50.278 |
Usædvanlig Udgift (Indkomst) | 8.9 | 18.994 | 26.678 | 95.399 | 1 | -31.508 |
Other Operating Expenses, Total | 16.954 | -3.423 | -16.816 | -14.854 | -3.989 | -1.703 |
Driftsindtægter | -96.551 | -276.442 | -171.197 | -274.052 | 57.714 | 18.75 |
Renteindkomst (Udgift), Netto Ikke-Drift | -4.174 | -5.939 | -7.607 | -19.632 | -21.732 | -18.006 |
Andre, Netto | 3.903 | 10.457 | 1.535 | -11.281 | 12.701 | -14.77 |
Netto Indkomst Før Skat | -96.822 | -271.924 | -177.269 | -304.965 | 48.683 | -14.026 |
Netto Indkomst Efter Skat | -40.707 | -290.779 | -138.543 | -312.025 | 31.066 | -29.515 |
Equity In Affiliates | -7.652 | -14.471 | -14.497 | -2.9 | -0.48 | -0.629 |
Netto Indkomst Før Ekstra Ting | -48.359 | -305.25 | -153.04 | -314.925 | 30.586 | -30.144 |
Netto Indkomst | -48.359 | -305.25 | -153.04 | -314.925 | 30.586 | -30.144 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -48.359 | -305.25 | -153.04 | -314.925 | 30.586 | -30.143 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -48.359 | -305.25 | -153.04 | -314.925 | 30.586 | -30.143 |
Fortyndet Netto Indkomst | -48.359 | -305.25 | -153.04 | -314.925 | 30.586 | -30.143 |
Fortyndet Vægtet Gennemsnit Aktier | 550.847 | 559.161 | 563.144 | 595.454 | 640.655 | 648.078 |
Fortyndet EPS Uden Ekstraordinære Ting | -0.08779 | -0.54591 | -0.27176 | -0.52888 | 0.04774 | -0.04651 |
Fortyndet Normaliseret EPS | -0.07729 | -0.52383 | -0.24097 | -0.42474 | 0.04874 | -0.07811 |
Totale Ekstraordinære Ting | 0 | |||||
Total Adjustments to Net Income | 0.001 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Total omsætning | 545.165 | 442.408 | 385.813 | 401.331 | 329.219 |
Omsætning | 545.165 | 442.408 | 385.813 | 401.331 | 329.219 |
Kost af omsætning, Total | 363.507 | 292.908 | 243.957 | 292.823 | 243.875 |
Bruttofortjeneste | 181.658 | 149.5 | 141.856 | 108.508 | 85.344 |
Totale Driftsudgifter | 506.728 | 436.837 | 347.987 | 464.415 | 401.643 |
Salgs/Generelle/Admin. Udgifter, Total | 112.286 | 113.236 | 105.12 | 138.214 | 117.537 |
Forskning & Udvikling | 19.315 | 18.222 | 18.306 | 21.007 | 18.312 |
Depreciation / Amortization | 12.577 | 12.574 | 12.609 | 12.518 | 22.025 |
Other Operating Expenses, Total | -0.957 | -0.103 | -0.497 | -0.147 | -0.106 |
Driftsindtægter | 38.437 | 5.571 | 37.826 | -63.084 | -72.424 |
Renteindkomst (Udgift), Netto Ikke-Drift | -5.829 | -5.153 | -2.998 | -4.026 | -2.784 |
Andre, Netto | -0.927 | -11.783 | -3.356 | 1.297 | -1.442 |
Netto Indkomst Før Skat | 31.681 | -11.365 | 31.472 | -65.813 | -76.65 |
Netto Indkomst Efter Skat | 31.121 | -16.119 | 28.792 | -73.309 | -55.384 |
Equity In Affiliates | -0.043 | -0.067 | -0.053 | -0.466 | -0.049 |
Netto Indkomst Før Ekstra Ting | 31.078 | -16.186 | 28.739 | -73.775 | -55.433 |
Netto Indkomst | 31.078 | -16.186 | 28.739 | -73.775 | -55.433 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 31.078 | -16.186 | 28.739 | -73.774 | -55.433 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 31.078 | -16.186 | 28.739 | -73.774 | -55.433 |
Fortyndet Netto Indkomst | 31.078 | -16.186 | 28.739 | -73.774 | -55.433 |
Fortyndet Vægtet Gennemsnit Aktier | 640.853 | 646.997 | 651.843 | 652.18 | 660.302 |
Fortyndet EPS Uden Ekstraordinære Ting | 0.04849 | -0.02502 | 0.04409 | -0.11312 | -0.08395 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Fortyndet Normaliseret EPS | 0.04849 | -0.02502 | 0.01267 | -0.11312 | -0.08395 |
Usædvanlig Udgift (Indkomst) | -31.508 | 0 | |||
Total Adjustments to Net Income | 0.001 |
- Årlig
- Pr kvartal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Totale Nuværende Aktiver | 483.601 | 348.861 | 317.731 | 324.045 | 523.179 | 823.013 |
Likvider og Kortsigtede Investeringer | 168.733 | 91.499 | 96.473 | 85.452 | 72.211 | 134.71 |
Likvider & Lignende | 168.733 | 91.499 | 96.473 | 85.452 | 72.211 | 134.71 |
Totale Tilgodehavender, Netto | 249.492 | 192.892 | 161.983 | 157.687 | 302.256 | 265.588 |
Accounts Receivable - Trade, Net | 220.284 | 165.516 | 143.907 | 134.617 | 286.314 | 259.637 |
Total Inventory | 47.228 | 49.333 | 42.299 | 53.434 | 132.341 | 86.502 |
Prepaid Expenses | 10.64 | 11.739 | 13.129 | 11.633 | 11.062 | 15.024 |
Other Current Assets, Total | 7.508 | 3.398 | 3.847 | 15.839 | 5.309 | 321.189 |
Total Assets | 2766.62 | 2589.96 | 2451.07 | 2309.27 | 2473.06 | 2399.72 |
Property/Plant/Equipment, Total - Net | 122.831 | 146.557 | 144.674 | 166.491 | 178.289 | 123.955 |
Property/Plant/Equipment, Total - Gross | 79.509 | 232.404 | 256.336 | 302.936 | 343.058 | 257.281 |
Accumulated Depreciation, Total | -56.778 | -85.847 | -111.662 | -136.445 | -164.769 | -133.326 |
Goodwill, Net | 704.603 | 717.099 | 700.193 | 671.94 | 680.602 | 520.601 |
Intangibles, Net | 1408.69 | 1331.18 | 1250.02 | 1119.16 | 1065.2 | 911.883 |
Long Term Investments | 37.122 | 37.309 | 30.373 | 20.626 | 15.731 | 10.729 |
Other Long Term Assets, Total | 9.773 | 8.948 | 8.077 | 7.008 | 10.06 | 9.534 |
Total Current Liabilities | 263.296 | 312.029 | 288.321 | 249.119 | 375.483 | 330.008 |
Accounts Payable | 53.36 | 74.307 | 47.395 | 62.537 | 100.883 | 82.04 |
Accrued Expenses | 117.066 | 160.588 | 133.476 | 154.891 | 231.661 | 202.602 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 15.006 | 15.325 | 40.693 | 12.362 | 27.156 | 16.952 |
Other Current Liabilities, Total | 77.864 | 61.809 | 66.757 | 19.329 | 15.783 | 28.414 |
Total Liabilities | 674.811 | 746.333 | 659.781 | 694.513 | 801.512 | 714.589 |
Total Long Term Debt | 73.707 | 142.665 | 172.771 | 263.909 | 228.631 | 193.083 |
Long Term Debt | 66.491 | 134.879 | 167.151 | 259.863 | 225.826 | 190.159 |
Capital Lease Obligations | 7.216 | 7.786 | 5.62 | 4.046 | 2.805 | 2.924 |
Deferred Income Tax | 165.331 | 148.729 | 115.193 | 118.717 | 137.208 | 148.487 |
Other Liabilities, Total | 172.477 | 142.91 | 83.496 | 62.768 | 60.19 | 43.011 |
Total Equity | 2091.81 | 1843.62 | 1791.29 | 1614.76 | 1671.55 | 1685.13 |
Common Stock | 5.586 | 5.6 | 5.869 | 6.704 | 6.706 | 6.901 |
Additional Paid-In Capital | 2845.1 | 2889.26 | 3004.42 | 3142.99 | 3152.69 | 3222.49 |
Retained Earnings (Accumulated Deficit) | -729.954 | -1048.91 | -1197.08 | -1511.08 | -1481.83 | -1511.98 |
Treasury Stock - Common | -1.911 | -1.791 | -1.791 | -1.791 | -1.791 | -1.791 |
Unrealized Gain (Loss) | -0.263 | 4.876 | 0 | |||
Other Equity, Total | -26.746 | -5.404 | -20.131 | -22.07 | -4.225 | -30.495 |
Total Liabilities & Shareholders’ Equity | 2766.62 | 2589.96 | 2451.07 | 2309.27 | 2473.06 | 2399.72 |
Total Common Shares Outstanding | 557.989 | 559.474 | 586.332 | 669.829 | 670.036 | 681.427 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 599.049 | 547.029 | 557.51 | 823.013 | 754.069 |
Likvider og Kortsigtede Investeringer | 89.503 | 65.757 | 148.599 | 134.71 | 102.281 |
Likvider & Lignende | 89.503 | 65.757 | 148.599 | 134.71 | 102.281 |
Totale Tilgodehavender, Netto | 330.293 | 275.639 | 265.527 | 265.588 | 221.295 |
Accounts Receivable - Trade, Net | 320.462 | 265.856 | 255.192 | 259.637 | 212.755 |
Total Inventory | 159.104 | 134.722 | 112.861 | 86.502 | 99.406 |
Prepaid Expenses | 15.086 | 21.967 | 19.52 | 15.024 | 9.902 |
Other Current Assets, Total | 5.063 | 48.944 | 11.003 | 321.189 | 321.185 |
Total Assets | 2519.57 | 2421.65 | 2417.64 | 2399.72 | 2306.86 |
Property/Plant/Equipment, Total - Net | 177.7 | 143.001 | 141.002 | 123.955 | 124.667 |
Goodwill, Net | 676.162 | 677.36 | 674.574 | 520.601 | 519.052 |
Intangibles, Net | 1046.51 | 1035.71 | 1024.06 | 911.883 | 890.498 |
Long Term Investments | 10.41 | 8.945 | 11.753 | 10.729 | 9.472 |
Other Long Term Assets, Total | 9.745 | 9.6 | 8.744 | 9.534 | 9.1 |
Total Current Liabilities | 403.93 | 303.98 | 283.035 | 330.008 | 309.17 |
Accounts Payable | 162.69 | 88.512 | 94.393 | 82.04 | 94.24 |
Accrued Expenses | 206.106 | 186.79 | 168.936 | 202.602 | 166.297 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 20.103 | 20.045 | 16.702 | 16.952 | 19.863 |
Other Current Liabilities, Total | 15.031 | 8.633 | 3.004 | 28.414 | 28.77 |
Total Liabilities | 823.061 | 679.065 | 652.071 | 714.589 | 691.974 |
Total Long Term Debt | 230.613 | 189.727 | 189.516 | 193.083 | 216.358 |
Long Term Debt | 228.107 | 187.168 | 187.214 | 190.159 | 212.493 |
Capital Lease Obligations | 2.506 | 2.559 | 2.302 | 2.924 | 3.865 |
Deferred Income Tax | 135.244 | 136.416 | 134.247 | 148.487 | 125.03 |
Other Liabilities, Total | 53.274 | 48.942 | 45.273 | 43.011 | 41.416 |
Total Equity | 1696.51 | 1742.58 | 1765.57 | 1685.13 | 1614.88 |
Common Stock | 6.707 | 6.898 | 6.9 | 6.901 | 6.902 |
Additional Paid-In Capital | 3155.65 | 3214.35 | 3218.58 | 3222.49 | 3191.14 |
Retained Earnings (Accumulated Deficit) | -1450.76 | -1466.94 | -1438.2 | -1511.98 | -1549.95 |
Treasury Stock - Common | -1.791 | -1.791 | -1.791 | -1.791 | -1.791 |
Other Equity, Total | -13.295 | -9.932 | -19.923 | -30.495 | -31.415 |
Total Liabilities & Shareholders’ Equity | 2519.57 | 2421.65 | 2417.64 | 2399.72 | 2306.86 |
Total Common Shares Outstanding | 670.153 | 681.163 | 681.342 | 681.427 | 681.483 |
- Årlig
- Pr kvartal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Netto indkomst/Startlinje | -48.359 | -305.25 | -153.04 | -314.925 | 30.586 | -30.143 |
Likvider Fra Driftsaktiviteter | 32.046 | -92.08 | -109.141 | -172.522 | 39.476 | 38.337 |
Likvider Fra Driftsaktiviteter | 96.576 | 102.093 | 97.344 | 93.807 | 85.362 | 78.716 |
Deferred Taxes | -66.3 | 16.092 | -35.133 | 4.324 | 15.64 | 10.159 |
Ikke-Likvide Ting | 70.062 | 46.633 | 39.832 | 113.079 | 5.497 | 0.087 |
Cash Taxes Paid | -27.122 | 5.416 | 1.41 | -2.667 | 0.903 | 5.969 |
Likvid Rente Betalt | 2.89 | 1.313 | 2.076 | 11.873 | 10.908 | 8.515 |
Ændringer i Driftskapital | -19.933 | 48.352 | -58.144 | -68.807 | -97.609 | -20.482 |
Likvider fra Investeringsaktiviteter | -20.702 | -46.667 | -26.119 | -13.27 | -18.327 | 35.949 |
Kapitaludgifter | -23.547 | -46.524 | -27.858 | -12.741 | -33.682 | -32.156 |
Andre Investerings-Cash-Flow-Ting, Total | 2.845 | -0.143 | 1.739 | -0.529 | 15.355 | 68.105 |
Likvider fra Financieringsaktiviteter | -35.195 | 61.043 | 140.909 | 175.248 | -35.076 | -10.351 |
Udstedelse (Pensionering) af Aktier, Netto | 8.576 | 2.132 | 148.673 | 276.352 | 0.756 | 1.08 |
Udstedelse (Pensionering) af Gæld, Netto | -43.771 | 58.911 | -7.764 | -93.342 | -35.832 | -11.243 |
Udenlandsk Børs Effekter | -1.014 | 0.47 | -0.675 | -0.477 | 0.686 | -1.436 |
Netto Ændring i Likviditet | -24.865 | -77.234 | 4.974 | -11.021 | -13.241 | 62.499 |
Financiering af Cash-Flow-Ting | -7.762 | 0 | -0.188 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 31.078 | 14.892 | 43.631 | -30.143 | -55.433 |
Cash From Operating Activities | 26.037 | 10.584 | 43.98 | 38.337 | -19.856 |
Cash From Operating Activities | 19.989 | 40.561 | 59.525 | 78.716 | 27.814 |
Deferred Taxes | -1.033 | 2.479 | 2.378 | 10.159 | -22.356 |
Non-Cash Items | 1.222 | 19.401 | -9.952 | 0.087 | 9.879 |
Cash Taxes Paid | 1.47 | 3.69 | 5.509 | 5.969 | 1.063 |
Cash Interest Paid | 4.689 | 4.883 | 8.386 | 8.515 | 3.42 |
Changes in Working Capital | -25.219 | -66.749 | -51.602 | -20.482 | 20.24 |
Cash From Investing Activities | -1.106 | -9.948 | 44.628 | 35.949 | -4.903 |
Capital Expenditures | -9.245 | -18.192 | -25.426 | -32.156 | -5.251 |
Other Investing Cash Flow Items, Total | 8.139 | 8.244 | 70.054 | 68.105 | 0.348 |
Cash From Financing Activities | -7.192 | -6.927 | -11.183 | -10.351 | -7.891 |
Issuance (Retirement) of Stock, Net | 0.308 | 0.466 | 0.879 | 1.08 | 0.136 |
Issuance (Retirement) of Debt, Net | -7.5 | -7.393 | -11.874 | -11.243 | -8.027 |
Foreign Exchange Effects | -0.447 | -0.163 | -1.037 | -1.436 | 0.221 |
Net Change in Cash | 17.292 | -6.454 | 76.388 | 62.499 | -32.429 |
Financing Cash Flow Items | -0.188 | -0.188 |
Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
---|---|---|---|---|---|---|
Frost Gamma Investments Trust | Corporation | 26.405 | 204027475 | 200000 | 2022-11-23 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 5.2039 | 40209654 | -2296471 | 2022-09-30 | LOW |
Holbrook (Bruce C) | Individual Investor | 5.1484 | 39781126 | 39781126 | 2022-05-10 | |
Hsiao (Jane H) | Individual Investor | 4.2355 | 32727274 | 0 | 2022-07-28 | |
Frost Group, L.L.C. | Corporation | 3.899 | 30127177 | 0 | 2022-08-17 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 3.8394 | 29666569 | -351756 | 2022-09-30 | LOW |
GJN 2021 Trust | Corporation | 2.5699 | 19857514 | 19857514 | 2022-06-22 | |
EGN 2021 Trust | Corporation | 2.5699 | 19857514 | 19857514 | 2022-06-22 | |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.4008 | 10823641 | 1744961 | 2022-09-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 1.3426 | 10374273 | 507764 | 2022-09-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.0132 | 7829188 | 200456 | 2022-09-30 | LOW |
Rubin (Steven D) | Individual Investor | 0.7969 | 6157732 | 0 | 2022-05-23 | |
D. E. Shaw & Co., L.P. | Hedge Fund | 0.7724 | 5968306 | -397910 | 2022-09-30 | MED |
Oracle Investment Management, Inc. | Investment Advisor/Hedge Fund | 0.6604 | 5102756 | -2150000 | 2022-09-30 | MED |
Two Sigma Investments, LP | Hedge Fund | 0.6484 | 5009766 | 2467029 | 2022-09-30 | HIGH |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.5534 | 4276383 | 1215448 | 2021-12-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.4935 | 3813530 | 420857 | 2022-09-30 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.4461 | 3446571 | -87509 | 2022-09-30 | LOW |
Invesco Capital Management LLC | Investment Advisor | 0.4186 | 3234077 | 709875 | 2022-09-30 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.3671 | 2836343 | -1053829 | 2022-09-30 | HIGH |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com GroupHandlende
Månedlkige, aktive klienter
Månedlig investeringsvolumen
Hævet hver måned
Handelslommeregner
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
OPKO Health, Inc. Company profile
Om OPKO Health, Inc.
OPKO Health, Inc. er en virksomhed inden for sundhedssektoren. Selskabets segmenter omfatter diagnostik og farmaceutiske produkter. Diagnostiksegmentet består af Bio-Reference Laboratories' (Bio-Reference) kliniske laboratorieaktiviteter og dets point-of-care-aktiviteter. Farmaceutisk segment består af de farmaceutiske aktiviteter i Chile, Mexico, Irland, Israel og Spanien samt dets farmaceutiske forsknings- og udviklingsaktiviteter. Gennem Bio-Reference driver selskabet laboratorieafdelinger, såsom Bio-Reference, GenPath (Onkologi), GenPath (Kvindesundhed) og GeneDx. Virksomhedens farmaceutiske aktiviteter har et farmaceutisk produkt på kommercielt niveau og flere farmaceutiske forbindelser og teknologier på forskellige forsknings- og udviklingsstadier for en række indikationer og tilstande, herunder nyreprodukter, oxyntomodulin, biologiske produkter, faktor VIIa -CTP og hGH-CTP. Selskabet ejer også en producent af aktive farmaceutiske ingredienser (API'er) i Israel gennem sit datterselskab FineTech Pharmaceutical, Ltd.
Industry: | Pharmaceuticals (NEC) |
4400 Biscayne Blvd.
MIAMI
FLORIDA 33137
US
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 485.000+ handlende over hele verden, der valgte at handle hos Capital.com